April 2021

Research Opportunities, Patient Care Attracted HOPA President to Career in Oncology Pharmacy

April 28, 2021

Directions in Oncology Pharmacy® is getting to know oncology pharmacy professionals through a series of interviews. In this issue, we talk to David DeRemer, PharmD, BCOP, FCCP, FHOPA, president of the Hematology/Oncology Pharmacy Association (HOPA) Board of Directors, whose term ends this month.

Personalizing Neoadjuvant and Adjuvant HER2-Targeted Therapy for Breast Cancer

April 06, 2021

Understanding breast cancer and which patients may be more vulnerable to long-term treatment effects and which patients may benefit most, can help oncologists design the best personalized neoadjuvant and adjuvant human epidermal growth factor receptor 2 (HER2)-targeted therapy.